Marcy-l'Etoile, France

Richard Brebant


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Richard Brebant in Virus Detection

Introduction

Richard Brebant is an inventive mind located in Marcy-l'Etoile, France. He has made significant contributions in the field of medical diagnostics, particularly in the detection of viral infections. With a noteworthy patent to his name, Brebant continues to work towards advancing healthcare technology.

Latest Patents

Richard Brebant holds a patent for a peptide reagent that enables the detection of a primary Epstein-Barr virus infection by testing for corresponding antibodies. This invention details a method of using the reagent to test for IgM antibodies within a biological sample, which allows for early detection of the viral infection. The reagent contains a specific peptide recognized by antibodies that have the sequence of formula (II): Leu Glu Ile Lys Arg Tyr Lys Asn Arg Val Ala Ser Arg Lys Cys Arg Ala Lys Phe Lys Gln. This innovation plays a crucial role in improving diagnostic capabilities for Epstein-Barr virus infections.

Career Highlights

Breabant is affiliated with Université Joseph Fourier, where he dedicates his efforts to research and development in the field of immunology and viral diagnostics. His commitment to innovation has positioned him as a respected figure in his field, particularly in the development of early detection methods for viral infections.

Collaborations

In his professional journey, Richard Brebant collaborates with Emmanuel Drouet, contributing to advancements in medical research. Their combined expertise enables them to tackle complex challenges within the realm of viral detection and diagnostics.

Conclusion

Richard Brebant's innovations in viral detection highlight the importance of early diagnostic methods in improving patient outcomes. His work at Université Joseph Fourier and his collaboration with Emmanuel Drouet exemplify a commitment to scientific advancement and public health. With his patent, Brebant is paving the way for more effective detection strategies for the Epstein-Barr virus, marking a significant step forward in the medical research community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…